21:40:51 EDT Tue 29 Apr 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HBP - T  1.00.77·0.781.00.7836.027230.78  0.78  0.781.35  0.5014:10:01Apr 2415 min RT 2¢
TSX - T1.00.77·0.781.00.7828.021140.78  0.78  0.781.35  0.5012:13:4515 min
NEO ATS - U 0.780.5010.78  0.78  0.7812:13:5615 min
Omega - O 0.787.5560.78  0.78  0.7814:10:0115 min
CXD - D 0.780.0011    Nov 1215 min
TriAct - M 0.780.011    Sep 01/2015 min

Recent Trades - Last 10 of 23
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:32:30M0.77-0.011080 National Bank80 National BankE
14:10:01O0.78 50084 ITG8414 Virtu ITGK
12:45:00O0.78 1,0002 RBC14 Virtu ITGK
12:31:08D0.78 180 National Bank80 National BankE
12:29:20O0.78 50084 ITG8414 Virtu ITGK
12:13:56U0.78 50084 ITG842 RBCK
12:13:45T0.78 50084 ITG841 AnonymousK
12:13:01T0.78 50084 ITG841 AnonymousK
12:12:37T0.78 50084 ITG841 AnonymousK
12:09:19O0.78 1,0002 RBC14 Virtu ITGK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-24 17:58C:HBP0.78News ReleaseHelix Bio appoints Kandziora, Kourniaktis as execs
2025-04-10 17:57C:HBP0.79News ReleaseHelix BioPharma promotes Mehrling to CEO
2025-04-03 17:30C:HBP0.79News ReleaseHelix BioPharma hires ITG for market-making services
2025-03-26 18:19C:HBP0.80News ReleaseHelix BioPharma holders approve all matters at AGSM
2025-03-18 08:40C:HBP0.90News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three and Six Month Periods Ended January 31, 2025
2025-03-14 19:34C:HBP0.90SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-03-14 19:34C:HBP0.90SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-11 17:50C:HBP0.88News ReleaseHelix's L-DOS47 presentation to be held March 12
2025-03-06 17:48C:HBP0.91News ReleaseHelix BioPharma adds Guggi as CTO, Mehrling as CMO
2025-03-03 20:36C:HBP0.91News ReleaseHelix BioPharma extends AGSM date to March 26
2025-02-24 08:51C:HBP0.98News ReleaseHelix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing
2025-02-21 20:07C:HBP0.98News ReleaseHelix BioPharma pushes AGSM date to March 26
2025-01-09 19:36C:HBP0.93News ReleaseHelix BioPharma closes $3-million private placement
2024-12-16 17:18C:HBP0.95SEDAR Interim MD & ASEDAR Interim MD & A
2024-12-16 17:11C:HBP0.95SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-12-11 18:42C:HBP0.87News ReleaseHelix BioPharma appoints Murphy as CFO
2024-12-06 17:57C:HBP0.94News ReleaseHelix BioPharma tweaks Laevoroc agreements
2024-12-03 04:21C:HBP0.95News ReleaseHelix to acquire Laevoroc, Gemceda for shares
2024-11-29 16:18C:HBP0.87News ReleaseHelix firms up Laevoroc asset acquisition
2024-11-21 17:40C:HBP0.70News ReleaseHelix BioPharma adds U.S. antibody patent